Inspection Record

Civic Center Pharmacy Inc. — FDA 483 Findings

US FDAInspected 2017-04-24Published 2024-01-17 5 findingsAseptic processing and sterility assuranceTraining and personnelDocumentation and records

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

The final containers/closures used for drug product intended to be sterile have not been sterilized or de pyrogenated.

2Training and personnel

Personnel were observed using a non-sterile tool or manually contact the inner surface of the container or closure.

3Documentation and records

The batch records do not record the distinctive identification number, code and name of equipment to identifY major equipment to show the specific equipment used in the manufacture of a batch of a drug product.

4Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding air supply that is filtered through high-efficiency particulate air filters under positive pressure.

5Aseptic processing and sterility assurance

There is inadequate HEPA filter coverage or airflow over the area to which sterile product is exposed.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Civic Center Pharmacy Inc. company profile — full history US FDA documents, 2024 Go to Findings search